JP2025510948A5 - - Google Patents
Info
- Publication number
- JP2025510948A5 JP2025510948A5 JP2024557470A JP2024557470A JP2025510948A5 JP 2025510948 A5 JP2025510948 A5 JP 2025510948A5 JP 2024557470 A JP2024557470 A JP 2024557470A JP 2024557470 A JP2024557470 A JP 2024557470A JP 2025510948 A5 JP2025510948 A5 JP 2025510948A5
- Authority
- JP
- Japan
- Prior art keywords
- individually
- sequence numbers
- numbers
- sequence
- individually sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263326269P | 2022-03-31 | 2022-03-31 | |
| US63/326,269 | 2022-03-31 | ||
| US202263341681P | 2022-05-13 | 2022-05-13 | |
| US63/341,681 | 2022-05-13 | ||
| PCT/US2023/065233 WO2023193003A2 (en) | 2022-03-31 | 2023-03-31 | Cd4-specific antibody constructs and compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510948A JP2025510948A (ja) | 2025-04-15 |
| JP2025510948A5 true JP2025510948A5 (enExample) | 2026-04-08 |
Family
ID=88203505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557470A Pending JP2025510948A (ja) | 2022-03-31 | 2023-03-31 | Ｃｄ４特異的抗体構築物及び組成物ならびにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250281536A1 (enExample) |
| EP (1) | EP4499706A4 (enExample) |
| JP (1) | JP2025510948A (enExample) |
| KR (1) | KR20250005572A (enExample) |
| CN (1) | CN119317642A (enExample) |
| AU (1) | AU2023243626A1 (enExample) |
| CA (1) | CA3255336A1 (enExample) |
| IL (1) | IL315572A (enExample) |
| WO (1) | WO2023193003A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4590688A1 (en) * | 2022-09-21 | 2025-07-30 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| JP2026523670A (ja) * | 2024-03-08 | 2026-07-14 | サンメッド セラピューティック リミテッド | 抗ガレクチン３抗体ならびに癲癇および関連疾患におけるその使用 |
| CN118146376B (zh) * | 2024-05-09 | 2024-07-05 | 成都微芯新域生物技术有限公司 | Hla-g抗体及其制备方法和用途 |
| WO2026096278A1 (en) * | 2024-10-29 | 2026-05-07 | Mayo Foundation For Medical Education And Research | Molecules that bind to b7 homolog 3 polypeptides |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69126301T2 (de) * | 1990-11-27 | 1998-01-02 | Biogen, Inc., Cambridge, Mass. | Hiv-induzierte synzytien blockierender anti-cd-4-antikörper |
| WO2010043650A2 (en) * | 2008-10-14 | 2010-04-22 | Ablynx Nv | Amino acid sequences directed against cellular receptors for viruses and bacteria |
| ES2602459T3 (es) * | 2008-12-26 | 2017-02-21 | Kyowa Hakko Kirin Co., Ltd. | Anticuerpo anti-CD4 |
| EP3235908A1 (en) * | 2016-04-21 | 2017-10-25 | Ecole Normale Superieure De Lyon | Methods for selectively modulating the activity of distinct subtypes of cells |
| EP3448987A4 (en) * | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| BR112020016570A2 (pt) * | 2018-02-17 | 2020-12-15 | Flagship Pioneering Innovations V, Inc. | Composições e métodos para liberação de proteína de membrana |
| AU2019234183B2 (en) * | 2018-03-15 | 2025-12-18 | Biond Biologics Ltd. | Methods and compositions for decreasing soluble immune receptor CD28 |
| US12036242B2 (en) * | 2018-07-05 | 2024-07-16 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | CAR T cells that target B-cell antigens |
| EP4381081A1 (en) * | 2021-08-04 | 2024-06-12 | Sana Biotechnology, Inc. | Use of cd4-targeted viral vectors |
-
2023
- 2023-03-31 JP JP2024557470A patent/JP2025510948A/ja active Pending
- 2023-03-31 WO PCT/US2023/065233 patent/WO2023193003A2/en not_active Ceased
- 2023-03-31 US US18/852,220 patent/US20250281536A1/en active Pending
- 2023-03-31 CA CA3255336A patent/CA3255336A1/en active Pending
- 2023-03-31 EP EP23782106.1A patent/EP4499706A4/en active Pending
- 2023-03-31 IL IL315572A patent/IL315572A/en unknown
- 2023-03-31 KR KR1020247035855A patent/KR20250005572A/ko active Pending
- 2023-03-31 CN CN202380043231.8A patent/CN119317642A/zh active Pending
- 2023-03-31 AU AU2023243626A patent/AU2023243626A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532963A5 (enExample) | ||
| KR102946697B1 (ko) | 키메라 분자 및 그의 용도 | |
| JP2023060000A (ja) | レトロウイルスおよびレンチウイルスベクター | |
| JP7669327B2 (ja) | ナチュラルキラー細胞免疫療法における切断されたｎｋｇ２ｄキメラ受容体及びその使用 | |
| US20220396625A1 (en) | Targeting pd-l1 on tumor cells | |
| JP5553989B2 (ja) | ウィルスベクターを使用した標的化遺伝子送達方法 | |
| AU2021230545A1 (en) | Improved methods and compositions for modulating a genome | |
| CA3140064A1 (en) | Lockr-mediated recruitment of car t cells | |
| JP2022513326A5 (enExample) | ||
| CN120936364A (zh) | 修饰的弹状病毒糖蛋白及其用途 | |
| KR20240013173A (ko) | Nkg2d-기초 키메라 항원 수용체 | |
| CA3255336A1 (en) | CD4-SPECIFIC ANTIBODY CONSTRUCTIONS AND ASSOCIATED COMPOSITIONS AND USES | |
| CN120302988A (zh) | 新型抗间皮素嵌合抗原受体和经修饰的免疫细胞 | |
| CA3230810A1 (en) | Gene sequence construct for gene therapy of human immunodeficiency virus infection | |
| WO2023030312A1 (zh) | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 | |
| KR20240019811A (ko) | Gpc3 결합 분자 | |
| KR20250060244A (ko) | 조작된 외피보유 벡터 및 이의 사용 방법 | |
| CN106467576A (zh) | 一种抗体融合蛋白及其制备方法与应用 | |
| Chiyyeadu | Antibody-based strategies for infectious diseases, regenerative medicine and cancer | |
| JP2025539364A (ja) | 遺伝子操作ｔ細胞 |